Make your drug development a success!

Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development.
PhinC Services
News

They trust us

Antoine Tarral
Antoine Tarral
Head of HAT Clinical Programme - DNDi
The PhinC Development team has accompanied us throughout this program. In particular, their expertise in pharmacokinetic modeling has enabled us to select the therapeutic dose and optimize the dose regimen. I most particularly appreciated their continuous involvement, their professionalism and their ability to work together with all the other actors involved in this program.
John DiBella
John DiBella
President, Lancaster Division - Simulations Plus, Inc. (NASDAQ: SLP)
Simulations Plus has formed a strong relationship with PhinC as we work together to drive increased adoption of physiologically-based pharmacokinetic (PBPK) modeling to support pharmaceutical research and development. Their talented team of scientists have become proficient users of our GastroPlus™ software platform, and we are confident that the services they provide to clients are valuable and greatly impact R&D productivity.
French Tech Paris-Saclay
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
MabDesign